Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating erythropoietic protoporphyria, X-linked protoporphyria, or congenital erythropoietic porphyria with glycine transport inhibitors

Methods of treating erythropoietic protoporphyria, X-linked protoporphyria, or congenital erythropoietic porphyria with glycine transport inhibitors

US Patent 11813257 · Granted Nov 14, 2023

Estimated economic value: $20,898,000 ⓘ

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-hemojuvelin (HJV) antibodies for treating myelofibrosis2025
Anti-hemojuvelin (HJV) antibodies for treating myelofibrosis2025
Anti-hemojuvelin (HJV) antibodies for treating myelofibrosis2025
Anti-hemojuvelin (HJV) antibodies for treating myelofibrosis2025
Procoagulant compounds2022
Chimeric clotting factors2021
Cyclic phosphates and cyclic phosphoramidates for the treatment of neurologic di2019
Procoagulant compounds2019
Chimeric clotting factors2019
Methods of increasing platelet and hematopoietic stem cell production2012
Methods of increasing platelet and hematopoietic stem cell production2011
Octahydro-pyrrolo[3,4-b]pyrrole N-oxides2011